Evidence map›Paper›PMID 34400345›Full record

ArticleClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases2022

Combined epidemiological and genomic analysis of nosocomial SARS-CoV-2 infection early in the pandemic and the role of unidentified cases in transmission.

Luke B Snell, Chloe L Fisher, Usman Taj, Oliver Stirrup, Blair Merrick, Adela Alcolea-Medina, Themoula Charalampous, Adrian W Signell, Harry D Wilson, Gilberto Betancor and 14 more

Abstract read
In one paragraph

Article in Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Real-Time Whole Genome Sequencing to Guide Patient-Tailored Therapy of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Luke B SnellCentre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, UK; Directorate of Infection, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Chloe L FisherGenomics Innovation Unit, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Usman TajDirectorate of Infection, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Oliver StirrupUniversity College London, Gower St, London, UK.
Blair MerrickCentre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, UK; Directorate of Infection, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Adela Alcolea-MedinaInfection Sciences, Viapath, St Thomas' Hospital, London, UK.
Themoula CharalampousCentre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, UK.
Adrian W SignellUniversity College London, Gower St, London, UK.
Harry D WilsonDepartment of Infectious Diseases, School of Immunological and Microbial Sciences, King's College London, UK.
Gilberto BetancorDepartment of Infectious Diseases, School of Immunological and Microbial Sciences, King's College London, UK.
Mark Tan Kia IkCentre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, UK.
Emma CunninghamInfection Sciences, Viapath, St Thomas' Hospital, London, UK.
Penelope R CliffInfection Sciences, Viapath, St Thomas' Hospital, London, UK.
Suzanne PickeringDepartment of Infectious Diseases, School of Immunological and Microbial Sciences, King's College London, UK.
Rui Pedro GalaoDepartment of Infectious Diseases, School of Immunological and Microbial Sciences, King's College London, UK.
Rahul BatraCentre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, UK; Directorate of Infection, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Stuart J D NeilDepartment of Infectious Diseases, School of Immunological and Microbial Sciences, King's College London, UK.
Michael H MalimDepartment of Infectious Diseases, School of Immunological and Microbial Sciences, King's College London, UK.
Katie J DooresDepartment of Infectious Diseases, School of Immunological and Microbial Sciences, King's College London, UK.
Sam T DouthwaiteDirectorate of Infection, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Gaia NebbiaCentre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, UK; Directorate of Infection, Guy's and St Thomas' NHS Foundation Trust, London, UK.
COVID-19 Genomics UK (COG-UK) consortium
Jonathan D EdgeworthCentre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, UK; Directorate of Infection, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Ali R AwanGenomics Innovation Unit, Guy's and St Thomas' NHS Foundation Trust, London, UK. Electronic address: ali.awan@kcl.ac.uk.

Funding

Medical Research Council MC_PC_15068Medical Research Council MC_PC_19027Medical Research Council MC_U117562207
6 · The paper itself

Abstract

objectivesTo analyse nosocomial transmission in the early stages of the coronavirus 2019 (COVID-19) pandemic at a large multisite healthcare institution. Nosocomial incidence is linked with infection control interventions.

methodsViral genome sequence and epidemiological data were analysed for 574 consecutive patients, including 86 nosocomial cases, with a positive PCR test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the first 19 days of the pandemic.

resultsForty-four putative transmission clusters were found through epidemiological analysis; these included 234 cases and all 86 nosocomial cases. SARS-CoV-2 genome sequences were obtained from 168/234 (72%) of these cases in epidemiological clusters, including 77/86 nosocomial cases (90%). Only 75/168 (45%) of epidemiologically linked, sequenced cases were not refuted by applying genomic data, creating 14 final clusters accounting for 59/77 sequenced nosocomial cases (77%). Viral haplotypes from these clusters were enriched 1-14x (median 4x) compared to the community. Three factors implicated unidentified cases in transmission: (a) community-onset or indeterminate cases were absent in 7/14 clusters (50%), (b) four clusters (29%) had additional evidence of cryptic transmission, and (c) in three clusters (21%) diagnosis of the earliest case was delayed, which may have facilitated transmission. Nosocomial cases decreased to low levels (0-2 per day) despite continuing high numbers of admissions of community-onset SARS-CoV-2 cases (40-50 per day) and before the impact of introducing universal face masks and banning hospital visitors.

conclusionGenomics was necessary to accurately resolve transmission clusters. Our data support unidentified cases-such as healthcare workers or asymptomatic patients-as important vectors of transmission. Evidence is needed to ascertain whether routine screening increases case ascertainment and limits nosocomial transmission.

Indexed as

COVID-19Cross InfectionDisease OutbreaksGenome, ViralGenomicsHospitalsHumansPandemicsSARS-CoV-2Healthcare-associated infectionMolecular epidemiologyNosocomial transmissionSARS-CoV-2Whole-genome sequencing

Identifiers

PMID34400345
PMCPMC8361005

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.